Skip to main content

Table 6 Stage I and Stage II results of the MSC meta-analysis (comparison with the GOLD classification)

From: Multiple Score Comparison: a network meta-analysis approach to comparison and external validation of prognostic scores

Stage

g

ADO

BODEupd

eBODE

BODE

SAFE

BODEx

DOSE

BAED

newGOLD

I

1

0.097 (0.07, 0.123)

        

I

2

0.098 (0.057, 0.139)

0.124 (0.078, 0.17)

 

0.098 (0.059, 0.137)

     

I

3

0.044 (−0.03, 0.117)

0.023 (−0.054, 0.099)

 

0.019 (−0.054, 0.091)

    

−0.011 (−0.053, 0.03)

I

4

0.042 (0.01, 0.074)

0.043 (0.008, 0.078)

 

0.049 (0.017, 0.081)

0.037 (0.005, 0.069)

   

−0.008 (−0.038, 0.022)

I

5

0.099 (0.076, 0.123)

    

0.056 (0.035, 0.076)

0.036 (0.015, 0.057)

0.032 (0.005, 0.058)

0.028 (0.008, 0.047)

I

6

0.076 (0.027, 0.126)

0.043 (−0.006, 0.092)

0.048 (0.004, 0.093)

0.043 (0.001, 0.085)

 

0.030 (−0.015, 0.074)

0.021 (−0.023, 0.065)

−0.017 (−0.079, 0.045)

0.008 (−0.031, 0.047)

II

 

0.083 (0.069, 0.097)

0.072 (0.051, 0.093)

0.069 (0.044, 0.093)

0.064 (0.045, 0.082)

0.052 (0.022, 0.082)

0.045 (0.029, 0.061)

0.027 (0.010, 0.045)

0.016 (−0.007, 0.038)

0.014 (0.001, 0.028)

  1. Abbreviations: MSC Multiple Score Comparison, GOLD Global initiative for chronic Obstructive Lung Disease, BODE Body mass index, airflow Obstruction, Dyspnoea and severe Exacerbations, BODE upd. BODE updated, ADO Age, Dyspnoea, airflow Obstruction (we use in our analysis the updated version of the ADO score), e-BODE severe acute exacerbation of COPD plus BODE, BODEx Body mass index, airflow Obstruction, Dyspnoea, severe acute Exacerbation of COPD, DOSE Dyspnoea, Obstruction, Smoking and Exacerbation frequency, SAFE Saint George’s Respiratory Questionnaire (SGRQ) score, Air-Flow limitation and Exercise capacity, B-AE-D Body-mass index, Acute Exacerbations, Dyspnoea
  2. The first six rows show the Stage I results (group by group). The last row shows the Stage II results (namely the final results of the multiple score comparison meta-analysis)
  3. The scores are ordered by performance of the prognostic scores in Stage II